A hematologist with expertise in the treatment of multiple myeloma, Richa Parikh, MD, is an attending physician practicing at Winship Cancer Institute at Emory Midtown. Dr. Parikh serves as an assistant professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Prior to joining Emory, she was on faculty and served as an academic hospitalist on the multiple myeloma service at University of Arkansas for Medical Sciences Myeloma Center in Little Rock, Arkansas.
Dr. Parikh received her medical degree from the Grant Government Medical College & Sir J.J. Group of Hospitals in Mumbai, India. She completed her internal medicine residency at University of Arkansas for Medical Sciences in Little Rock, Arkansas. She then completed her hematology and medical oncology fellowship at Karmanos Cancer Institute/ Wayne State University in Detroit, Michigan.
Titles & Roles
Assistant Professor, Department of Hematology and Medical Oncology
Emory University School of Medicine
Education & Training
Education
Fellowship, Hematology/Oncology, 2024
Wayne State Univ./Detroit Med. Ctr.
Residency, Internal Medicine, 2019
University of Arkansas for Medical Sciences
Medical Education, MD, 2014
Grant Government Medical College
Board Certifications
Medical Oncology
American Board of Internal Medicine, 2023
Internal Medicine
American Board of Internal Medicine, 2019
Hematology
American Board of Internal Medicine,
Professional Memberships
American Society of Hematology
American Society of Oncology
American College of Physicians
Research
Dr. Parikh's major research focus is evaluating the impact of modifiable lifestyle factors like obesity, diabetes mellitus, diet, and gut microbiome on myeloma risk. Her other research interests include novel therapies for myeloma, autologous stem cell transplantation, and utilizing minimal residual disease testing to guide treatment strategies in plasma cell disorders.
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care.
Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to
all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations
behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful
for our patients, please click here.